Review
Nature Reviews Neuroscience 7, 860-872 (November 2006) | doi:10.1038/nrn2007
Macular degeneration: recent advances and therapeutic opportunities
Amir Rattner1 & Jeremy Nathans1,2 About the authors
Abstract
The central retina mediates high acuity vision, and its progressive dysfunction due to macular degeneration is the leading cause of visual disability among adults in industrialized societies. Here, we summarize recent progress in understanding the pathophysiology of macular degeneration and the implications of this new knowledge for treatment and prevention. The past decade has witnessed remarkable advances in this field, including the development of new, non-invasive retinal imaging technologies, the development of animal models for macular disease, and the isolation of many of the genes responsible for both early- and late-onset macular diseases. These advances have set the stage for the development of effective mechanism-based therapies.
- View At a Glance
Author affiliations
- Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
- Department of Neuroscience, Department of Ophthalmology, and the Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Correspondence to: Jeremy Nathans1,2 Email: jnathans@jhmi.edu
Published online 11 October 2006
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
The ABCs of AMDNature Medicine News and Views (01 Nov 1997)
Macrophages eyed in macular degenerationNature Medicine News and Views (01 Nov 2003)
See all 5 matches for News And ViewsRESEARCH
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient miceNature Medicine Article (01 Nov 2003)
Towards an understanding of age-related macular diseaseEye Original Article
See all 29 matches for Research
